Thnh phn: Glutathione 1650mg, EGF t nhau thai nga, vitamin C, vitamin E, alpha lipoic acid., u im: i tng s dng: Cch s dng: Lu : Gi tham kho: 760.000 VN/hp 90 vin
Objawem alarmowym jest silny, uporczywy bl brzucha, czsto promieniujcy do plecw, ktremu mog towarzyszy wymioty
555,556 To optimize and change the treatment strategy for autism, it is necessary to bridge biochemical molecular events, electrical oscillations and information processing and to explore the pathological mechanism of autism from a new systemic perspective
Inclusion Criteria Exclusion Criteria Timeline for a Trial Participant Screening Participants are screened for eligibility to participate in the trial Treatment Participants receive weekly subcutaneous injections of either CagriSema or Tirzepatide, with a dose escalation period followed by maintenance dosing Follow-up Participants are monitored for safety and effectiveness after treatment What Are the Treatments Tested in This Trial
